SATL1 Human Pre-designed siRNA Set A contains three designed siRNAs for SATL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Satratoxin G is a large cyclic mucor toxin. Satratoxin G induces apoptosis by activation of caspase [1][2].

SAV1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAV1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Saxagliptin Metabolite-15N,d2 hydrochloride is 15N and deuterated labeled Saxagliptin Metabolite.

SAXO1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAXO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAXO2 Human Pre-designed siRNA Set A contains three designed siRNAs for SAXO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SB 203580 sulfone is an analog of p38 MAP kinase inhibitor SB 203580, which inhibits the IL-1 production in monocytes with an IC50 of 0.2 μM and binds competitively with CSAID binding proteins (CSBP), inhibits it mediated stress response signaling with an IC50 of 0.03 μM[1].

SB-258585 is a selective ligand with high affinity for the 5-HT6 receptor, with a pKi value of 8.53[1].

SB02024 is a potent and orally active VPS34 inhibitor. SB02024 inhibits Vps34 kinase activity. SB02024 induces CCL5 and CXCL10 via STAT1/IRF7. SB02024 shows anticancer activity[1][2][3].

SB03178 is a fibroblast activation protein-alpha (FAP) inhibitor. SB03178 can be conjugated with DOTA and can be used for cancer research[1].

SB24011 is a STING-TRIM29 interaction inhibitor with a IC50 value of 3.85 μM. SB24011 enhances STING immunity by upregating STING protein levels, thereby enhancing the immunotherapy effect of STING agonists and anti-PD-1 antibodies through systemic anticancer immunity[1].

SBDS Human Pre-designed siRNA Set A contains three designed siRNAs for SBDS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBF1 Human Pre-designed siRNA Set A contains three designed siRNAs for SBF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBF2 Human Pre-designed siRNA Set A contains three designed siRNAs for SBF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBK1 Human Pre-designed siRNA Set A contains three designed siRNAs for SBK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBK2 Human Pre-designed siRNA Set A contains three designed siRNAs for SBK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBK3 Human Pre-designed siRNA Set A contains three designed siRNAs for SBK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBNO1 Human Pre-designed siRNA Set A contains three designed siRNAs for SBNO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBNO2 Human Pre-designed siRNA Set A contains three designed siRNAs for SBNO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBSN Human Pre-designed siRNA Set A contains three designed siRNAs for SBSN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SBSPON Human Pre-designed siRNA Set A contains three designed siRNAs for SBSPON gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SC5D Human Pre-designed siRNA Set A contains three designed siRNAs for SC5D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SC912 is an AR-V7 inhibitor (IC50 = 0.36 μM). SC912 possesses safety, potency and selectivity. SC912 binds directly to AR-FL and AR-V7 proteins, inhibites nuclear localization and chromatin binding capabilities. SC912 exerts anticancer activity through inhibition of proliferation, induction of cell cycle arrest and apoptosis[1].

SCAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAF11 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAF11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAF4 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAI Human Pre-designed siRNA Set A contains three designed siRNAs for SCAI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAMP2 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAMP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAMP3 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAMP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAMP4 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAMP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAMP5 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAMP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAND1 Human Pre-designed siRNA Set A contains three designed siRNAs for SCAND1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAP Human Pre-designed siRNA Set A contains three designed siRNAs for SCAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCAPER Human Pre-designed siRNA Set A contains three designed siRNAs for SCAPER gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCARA3 Human Pre-designed siRNA Set A contains three designed siRNAs for SCARA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCARA5 Human Pre-designed siRNA Set A contains three designed siRNAs for SCARA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCARB1 Human Pre-designed siRNA Set A contains three designed siRNAs for SCARB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCARB2 Human Pre-designed siRNA Set A contains three designed siRNAs for SCARB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCARF1 Human Pre-designed siRNA Set A contains three designed siRNAs for SCARF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCARF2 Human Pre-designed siRNA Set A contains three designed siRNAs for SCARF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCART1 Human Pre-designed siRNA Set A contains three designed siRNAs for SCART1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCCPDH Human Pre-designed siRNA Set A contains three designed siRNAs for SCCPDH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SCD Human Pre-designed siRNA Set A contains three designed siRNAs for SCD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Scd Rat Pre-designed siRNA Set A contains three designed siRNAs for Scd gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.